A Singapore press holdings portal


Wednesday, May 28, 2014


Nestle moves into medical skin treatments with new firm

Reuters | Wednesday, May 28, 2014

Nestle said it would acquire from Valeant the full rights to commercialise Restylane, Perlane and Emervel, products used for corrective facial aesthetic treatments, and Dysport, a dermatology treatment, in the United States and Canada.

No comments yet.
Be the first to post comment.